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Introduction: Brain metastasis in patients with primary esophageal carcinoma is rare and has a 
poor prognosis. Here we report a case with brain metastasis as the initial presentation for 
patient’s esophageal cancer.  
Case Presentation: A 59-year-old Caucasian female with history of diabetes mellitus type 2 and 
hypertension presented with worsening headaches and neck stiffness lasting 4 weeks. Soon 
thereafter, she developed imbalance and difficulty walking. A brain MRI was done and showed 
diffuse brain lesions with the largest being in the cerebellum. Patient was referred to our hospital 
and further investigations revealed that patient had primary esophageal adenocarcinoma. 
Discussion: Brain metastasis secondary to esophageal carcinoma is rare. In this patient, brain 
metastasis was the initial presentation from the underlying esophageal carcinoma.  
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INTRODUCTION 
 
Esophageal carcinoma has proven to be one 
of the most difficult malignancies to cure, 
compounded by an extremely poor 
prognosis. Esophageal carcinoma is the 
seventh leading cause of cancer deaths in 
men in the United States.  
The likelihood of brain metastasis 
from an esophageal carcinoma has been 
reported to be 1-5%.
1
 Studies indicate the 
median survival rate of an esophageal cancer 
with brain metastasis as 3.9 months, further 
worsening an already grim prognosis. 
 
CASE PRESENTATION 
 
A 59-year-old Caucasian female with a past 
medical history of diabetes mellitus type 2 
and hypertension presented with worsening 
headaches and neck stiffness for 4 weeks. 
Patient was seen by her primary care 
physician and diagnosed with an ear 
infection and was started on an antibiotic 
regimen. Soon thereafter, she developed 
imbalance and difficulty walking. As 
symptoms did not resolve, meclizine was 
added. Worsening headaches ensued with 
nausea and vomiting, mainly in the morning. 
She had some intermittent confusion, 
dizziness, and frequent falls. Subsequently, 
Brain Magnetic Resonance Imaging (MRI) 
was ordered. 
The brain MRI showed multiple 
brain lesions with the largest being in the  
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 Figure 1. T1 axial and coronal with gadolinium Brain MRI showing multiple brain metastatic lesions. 
  
cerebellum (Figure 1). At presentation, the 
rest of her review of systems was 
unremarkable and the patient had no other 
medical illnesses. On examination, her 
blood pressure was 167/100 mmHg, and had 
decreased motor activity in her left lower 
extremity with a 4/5 motor function 
compared to a 5/5 on the right side. She had 
intact sensations, normal deep tendon 
reflexes, and cranial nerves. Patient was 
noted to have ataxic gait and diplopia, but 
no papilledema was appreciated on the 
exam. The rest of her physical exam was 
unremarkable.  
Imaging included a CT of her chest, 
abdomen and pelvis, which showed two 
right lung upper lobe nodules, hilar 
lymphadenopathy, as well as incidental 
finding of bilateral acute pulmonary emboli. 
Biopsy to one of the lung nodules showed 
metastatic moderately differentiated 
adenocarcinoma, mostly of a gastrointestinal 
source. Upper endoscopy was performed 
and showed a gastro-esophageal (GE) 
junction malignant looking mass (Figure 2), 
which was biopsied and was found to be an 
adenocarcinoma. Colonoscopy was 
unremarkable. Venous Doppler US to her 
lower extremities showed right sided DVT. 
An IVC filter was placed. Anticoagulation 
was withheld due to multiple brain 
metastases and an increased risk of bleeding. 
A PET scan showed an increased uptake in 
the lung nodules, as well as the peri-hilar 
lymph nodes. Patient was started on 
Dexamethasone injections and received 
whole brain radiation therapy. She finished 
chemotherapy systemically. Since the tumor 
was Human Epidermal Growth Factor 
Receptor 2 positive (HER 2+) the patient 
received Herceptin based chemotherapy. 
Herceptin, as part of the systemic 
chemotherapy, has shown significant benefit 
in overall survival in HER 2+ metastatic 
esophageal GE junction tumors. Ultimately, 
the patient chose to pursue hospice care.   
 
DISCUSSION 
 
Common causes for brain metastasis are 
usually lung cancer, breast cancer, colorectal 
cancer and melanomas
2
 (Table 1). It has 
been suggested that the route of spread to 
the brain is via the vertebral venous system.
3
 
A study performed by Rice et al., showed 
that brain metastasis occurred in 20 of the 29 
cases a year after an esophagectomy was 
performed
4
, highlighting the importance of a 
neurological evaluation during an 
esophageal carcinoma follow up. While the 
median survival of stage IV esophageal 
carcinoma is 10 months and a 10% survival 
rate at 5 years
3
, the median survival rate 
with brain metastasis drops to 3.9 months.
4
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Figure 2. Upper endoscopy images demonstrating lower esophageal/GE junction mass biopsies consistent with 
adenocarcinoma. 
 
It has been suggested by Ogawa et 
al., that multimodal treatment may result in 
a better prognosis in cases of brain 
metastasis. A subgroup of patients with 
limited brain metastases
1,5,6 
and with good 
performance status who are also candidates 
for surgery, stereotactic radiosurgery, and/or 
radiotherapy may have slightly better 
outcomes than patients with several brain 
metastases and poor performance status.
3
 
Ogawa et al found that all patients who 
survived more than 1 year (14% of patients) 
had received both stereotactic radiosurgery 
as well as radiotherapy. Patients with 
esophageal carcinoma and brain metastases 
generally do poorly with a solitary brain 
lesion despite it being amenable to surgical 
treatment or above stated local modalities, 
however they may have a better outcome if 
they have a good Karnofsky Performance 
index, which translates into better 
tolerability for therapies and better 
prognosis.
3
 
The key message from this particular 
case is that a headache, which is sudden or 
recent in onset, in patients older than 40 
years, severe and progressive in nature, and 
associated with neurologic manifestations, 
such as cerebellar symptoms, should be 
further investigated with imaging modalities 
to rule out other less benign causes. Also, 
though it is rare, brain metastasis can still 
happen secondary to esophageal carcinoma.  
 
Table 1. Most common origin sites of brain 
metastasis.
6 
 
 
 
 
 
Common origins of brain metastasis: 
Lung Cancer 
Breast Cancer 
Colorectal Cancer 
Melanoma 
Renal Carcinoma  
Thyroid 
Unknown 
Bulb GE Junction Mass Linear Ulcers 
 2
nd
 Portion Duodenum 
Mass Esophagus 
 Distal Esophagus 
Normal Esophagus 
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